
GLP-1 Medications in 2026: Weight Loss, Heart Health, Fatty Liver, and Whole-Body Effects
GLP-1–based medications have evolved from diabetes drugs into therapies that impact obesity, cardiovascular disease, chronic kidney disease, fatty liver disease (MASH), and obstructive sleep apnea. At the same time, rapid weight loss can have effects on hair and muscle mass, which deserve proactive attention.




